Emerging Cancer Diagnostic Markets: Innovative Technologies and Strategic Profiles of Leading Suppliers
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
Current and Emerging Technologies
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
Artificial Intelligence
Flow Cytometry
Two Dimensional Gel Electrophoresis (2-DGE)
Biosensors
Competing/Complementing Technologies
a. CT b.
MRI c.
NMR d.
PET
e. Photonics Spectroscopy
Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics
market players and start-up companies with innovative technologies and
products, including:
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic
- Leica Biosystems
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako and others.
2021 US Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and
View Report2021 UK Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and
View ReportLiquid biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast–2026
DelveInsights Liquid Biopsy in Cancer Diagnostics Market Insights, Competitive Landscape and Market Forecast-2026 report delivers an in-depth understanding of liquid biopsy in cancer diagnostics and the historical and forecasted liquid
View ReportGlobal Liver Cancer Diagnostics Market Research Report 2021-2025
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Liver Cancer Diagnostics Report by Material, Application, and Geography Global
View ReportFill The Form For Sample Request